Relmada Therapeutics, Inc. (FRA:4E2)
Germany · Delayed Price · Currency is EUR 3.500
0.00 (0.00%)
At close: Nov 28, 2025
Relmada Therapeutics Market Cap
Relmada Therapeutics has a market cap or net worth of €285.23 million as of December 1, 2025. Its market cap has increased by 203.92% in one year.
Market Cap
285.23M
Enterprise Value
273.25M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.50
Market Cap Chart
Since June 20, 2014, Relmada Therapeutics's market cap has increased from 88.97M to 285.23M, an increase of 220.58%. That is a compound annual growth rate of 10.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 285.23M | 1,781.99% |
| Dec 31, 2024 | 15.16M | -86.56% |
| Dec 29, 2023 | 112.74M | 14.69% |
| Dec 30, 2022 | 98.29M | -82.11% |
| Dec 31, 2021 | 549.27M | 29.00% |
| Dec 31, 2020 | 425.81M | -13.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |